NPI: 1508845322 · HUNTINGTON, NY 11743 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/11/2006
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 01/11/2006 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,055 | $161K |
| 2019 | 15,896 | $731K |
| 2020 | 35,742 | $2.01M |
| 2021 | 57,791 | $2.50M |
| 2022 | 46,048 | $1.67M |
| 2023 | 44,041 | $1.55M |
| 2024 | 33,155 | $1.21M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 13,347 | 12,766 | $2.47M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,897 | 10,352 | $1.88M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,192 | 5,788 | $1.06M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7,133 | 6,403 | $611K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,135 | 3,059 | $576K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,224 | 2,160 | $356K |
| 36415 | Collection of venous blood by venipuncture | 27,496 | 17,008 | $349K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,495 | 2,376 | $349K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,260 | 2,217 | $328K |
| 80053 | Comprehensive metabolic panel | 13,583 | 12,545 | $234K |
| 96361 | Intravenous infusion, hydration; each additional hour | 936 | 906 | $156K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,886 | 5,514 | $98K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,047 | 4,632 | $88K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 120 | 120 | $78K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,616 | 3,282 | $77K |
| 86901 | 3,766 | 3,639 | $73K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,528 | 7,990 | $73K |
| 86850 | 3,762 | 3,636 | $71K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,536 | 3,263 | $67K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,703 | 2,643 | $65K |
| C1889 | Implantable/insertable device, not otherwise classified | 119 | 119 | $58K |
| 86900 | 3,763 | 3,638 | $57K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,293 | 2,015 | $52K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,140 | 2,967 | $49K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,602 | 13,540 | $42K |
| 71046 | Radiologic examination, chest; 2 views | 2,676 | 2,635 | $41K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 884 | 781 | $40K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,840 | 2,794 | $29K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 814 | 797 | $27K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 740 | 735 | $25K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 211 | 198 | $25K |
| 85730 | 4,363 | 4,200 | $23K | |
| 81001 | 6,193 | 5,965 | $23K | |
| 93975 | 76 | 73 | $17K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 138 | 138 | $17K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 97 | 97 | $15K |
| 84702 | 2,920 | 2,793 | $15K | |
| 59025 | Fetal non-stress test | 110 | 95 | $14K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,447 | 1,395 | $14K |
| J7030 | Infusion, normal saline solution , 1000 cc | 6,760 | 6,335 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,319 | 4,181 | $13K |
| 85610 | 3,952 | 3,817 | $12K | |
| 0225U | 1,614 | 1,591 | $12K | |
| 83880 | 733 | 711 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 626 | 613 | $11K |
| J3490 | Unclassified drugs | 2,837 | 2,329 | $10K |
| 87631 | 225 | 224 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,030 | 966 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 978 | 874 | $8K |
| 81025 | 2,138 | 2,109 | $6K | |
| 88304 | 163 | 162 | $6K | |
| 83690 | 3,679 | 3,517 | $6K | |
| 71045 | Radiologic examination, chest; single view | 3,171 | 3,068 | $6K |
| 81003 | 2,256 | 2,204 | $4K | |
| 36000 | 306 | 302 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 29 | 28 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 70 | 51 | $2K |
| 85027 | 733 | 633 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 196 | 187 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 12 | 12 | $2K |
| 82962 | 1,712 | 1,449 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,033 | 2,874 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,285 | 1,091 | $2K |
| 84484 | 3,292 | 3,018 | $2K | |
| 90715 | 97 | 97 | $2K | |
| C9399 | Unclassified drugs or biologicals | 25 | 25 | $2K |
| 88312 | 79 | 79 | $2K | |
| 76830 | Ultrasound, transvaginal | 104 | 103 | $2K |
| 87040 | 915 | 877 | $1K | |
| J2704 | Injection, propofol, 10 mg | 828 | 783 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,708 | 3,467 | $1K |
| 83605 | 1,193 | 1,128 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,483 | 1,314 | $1K |
| 83735 | 1,867 | 1,740 | $895.25 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,077 | 1,042 | $791.95 |
| 96376 | 70 | 65 | $776.34 | |
| 84443 | Thyroid stimulating hormone (TSH) | 502 | 493 | $755.23 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 29 | 29 | $718.15 |
| 85379 | 908 | 898 | $714.28 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 491 | 490 | $703.95 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 37 | 37 | $522.82 |
| 73110 | 33 | 32 | $478.74 | |
| 82803 | 42 | 40 | $465.97 | |
| 73562 | 39 | 36 | $432.75 | |
| 88307 | 12 | 12 | $430.24 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 265 | 246 | $409.63 |
| 87486 | 29 | 29 | $371.16 | |
| 73630 | 87 | 85 | $367.51 | |
| 87081 | 406 | 405 | $338.47 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 514 | 495 | $334.20 |
| 86703 | 52 | 51 | $333.32 | |
| J7050 | Infusion, normal saline solution, 250 cc | 127 | 64 | $308.21 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 560 | 554 | $293.25 |
| J1170 | Injection, hydromorphone, up to 4 mg | 114 | 87 | $281.19 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 228 | 202 | $272.21 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 29 | 29 | $270.45 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 121 | 119 | $267.49 |
| 87581 | 29 | 29 | $255.10 | |
| J2060 | Injection, lorazepam, 2 mg | 250 | 202 | $247.23 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 111 | 111 | $231.37 |
| 87186 | 170 | 166 | $228.05 | |
| 86803 | 65 | 64 | $223.87 | |
| 82040 | 37 | 37 | $187.39 | |
| 73610 | 85 | 83 | $167.28 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13 | 13 | $116.62 |
| Q3014 | Telehealth originating site facility fee | 13 | 13 | $106.25 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 245 | 231 | $98.44 |
| 84100 | 32 | 29 | $87.47 | |
| 73030 | 12 | 12 | $55.11 | |
| 87077 | 64 | 63 | $48.48 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 53 | 52 | $39.09 |
| 73130 | 57 | 57 | $20.63 | |
| 76376 | 27 | 27 | $0.00 | |
| 88313 | 12 | 12 | $0.00 | |
| 73590 | 14 | 14 | $0.00 | |
| 99080 | 89 | 12 | $0.00 | |
| 82550 | 12 | 12 | $0.00 | |
| 73090 | 30 | 30 | $0.00 |